A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
Clinical trial NCT02783573 · TERMINATED
Trial details
- NCT number
- NCT02783573
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2018-09-28
- Enrollment
- 1722
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.